Literature DB >> 1578309

Intrahepatic bile duct damage in children with Kawasaki disease.

B Bader-Meunier1, M Hadchouel, M Fabre, M D Arnoud, J P Dommergues.   

Abstract

Three children with Kawasaki disease had liver biopsies because of evidence of hepatic disease. Cholangitis or bile duct injury and proliferation were found. Similar damage to the hepatic ductular system may explain the hydrops of the gallbladder sometimes seen in this disease.

Entities:  

Mesh：

Year:  1992        PMID： 1578309     DOI： 10.1016/s0022-3476(05)80239-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  8 in total

1.  Abnormal liver panel in acute kawasaki disease.

Authors:  Mohammed Eladawy; Samuel R Dominguez; Marsha S Anderson; Mary P Glodé
Journal:  Pediatr Infect Dis J       Date:  2011-02       Impact factor: 2.129

2.  Acute severe hepatitis with coagulopathy: An unusual presentation of Kawasaki syndrome in association with Epstein-Barr virus.

Authors:  M M Gordon; E D Silverman; J H Kim; A M Huber; K Furuya
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

3.  Hepatic dysfunction secondary to Kawasaki disease: characteristics, etiology and predictive role in coronary artery abnormalities.

Authors:  Goshgar Mammadov; Hui Hui Liu; Wei Xia Chen; Guo Zhen Fan; Rui Xue Li; Fei Fei Liu; Sama Samadli; Jing Jing Wang; Yang Fang Wu; Huang Huang Luo; Dong Dong Zhang; Wei Wei; Peng Hu
Journal:  Clin Exp Med       Date:  2019-11-16       Impact factor: 3.984

4.  Relationship between gallbladder distension and lipid profiles in kawasaki disease.

Authors:  Ki-Won Kim; Hak Yong Kim; Jin-Kyong Chun; Byung Ho Cha; Mee Kyung Namgoong; Woocheol Kwon; Hae Yong Lee
Journal:  Korean Circ J       Date:  2010-03-24       Impact factor: 3.243

5.  Utility of Soluble CD163 in the Clinical Management of Patients With Kawasaki Disease.

Authors:  Yoshihiro Azuma; Yasuo Suzuki; Seigo Okada; Chie Matsuguma; Hiroyuki Wakiguchi; Yuji Ohnishi; Takashi Furuta; Akiko Miyake; Hiroki Yasudo; Kiyoshi Ichihara; Shouichi Ohga; Shunji Hasegawa
Journal:  Front Pediatr       Date:  2020-04-07       Impact factor: 3.418

6.  Efficacy evaluation and mechanical study of short- and long-term antithrombotic therapy for Kawasaki disease.

Authors:  Jingxia Hao; Hua Wang; Jingshi Chen; Bo Li; Huimin Zhang; Yingqian Zhang
Journal:  Transl Pediatr       Date:  2021-07

Review 7.  Hepatic predominant presentation of Kawasaki disease in adolescence case report and review of literature.

Authors:  Krishan Pratap; Logan S Gardner; David Gillis; Martin Newman; Dana Wainwright; Roger Prentice
Journal:  BMC Gastroenterol       Date:  2020-10-27       Impact factor: 3.067

8.  Acute cholestasis as uncommon onset of Kawasaki disease: a case report.

Authors:  Massimo Gallerani; Marco Pala; Fabio Fabbian; Alfredo De Giorgi
Journal:  BMC Gastroenterol       Date:  2020-10-28       Impact factor: 3.067
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.